The ethical challenge of infection-inducing challenge experiments
about
Ethical aspects of malaria control and researchNonhuman primate and human challenge models of pertussisThe ethics of biosafety considerations in gain-of-function research resulting in the creation of potential pandemic pathogens.Must research benefit human subjects if it is to be permissible?Evaluating the risks of clinical research: direct comparative analysis.TB Vaccines: The (Human) Challenge Ahead.Why the development of effective typhoid control measures requires the use of human challenge studies.The potential for a controlled human infection platform in Singapore.Experimental Helicobacter pylori infection in humans: a multifaceted challenge.Limits on risks for healthy volunteers in biomedical research.Differences in host susceptibility to disease progression in the human challenge model of Haemophilus ducreyi infection.Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki.Payments to normal healthy volunteers in phase 1 trials: avoiding undue influence while distributing fairly the burdens of research participation.Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers.The utility of human challenge studies in vaccine development: lessons learned from cholera.The current state of tuberculosis vaccinesEstimating Time of Infection Using Prior Serological and Individual Information Can Greatly Improve Incidence Estimation of Human and Wildlife Infections.A framework for Controlled Human Infection Model (CHIM) studies in Malawi: Report of a Wellcome Trust workshop on CHIM in Low Income Countries held in Blantyre, Malawi.Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1-3, 2010.Ethical considerations in Controlled Human Malaria Infection studies in low resource settings: Experiences and perceptions of study participants in a malaria Challenge study in Kenya.Ethical Criteria for Human Challenge Studies in Infectious Diseases.
P2860
Q26773470-BCA12C09-1881-4AE4-86A8-FB5F2A06A3EBQ26825510-9118F05F-FA7C-421A-8C3A-79ED6016226DQ30378554-194457E0-7ECA-471A-81C1-16888951FFCCQ33363804-897D7EF7-27F0-41C5-A76F-4556636E92CFQ34171698-F5394A78-52E3-419A-8B9F-5B64AFB034A8Q34676075-21E469C0-144B-4179-A8D0-467E8EA9E44BQ34709684-5DECA458-3711-4309-B395-75128156CF77Q34952265-FAA9C0C2-D298-4AF4-8BE3-2DA35E3D3E2EQ35596807-4A3A2E21-B568-4F07-8E76-F32CFFBE1CC3Q36238424-14EC92BF-7C28-424A-AB94-E48F35327EF0Q36376430-47C817A5-D100-4E5D-9163-CA5704DBD0B3Q37052790-1EDDBFA4-360F-4180-A119-68AAA9C5B63FQ37192426-5E94D248-8AB5-410C-B913-2A1A1334BAB5Q37463375-7494A6BC-53CD-4AC4-A26E-E7E4B7365C9CQ37523806-A523026C-C7D0-4F09-8794-E3E116E94BCAQ38116351-607E502F-A41A-4BA9-9078-2C7E4E314323Q39768269-61991A72-81B6-4A4B-AA4D-816EA201FC18Q42039444-FD6DE4DA-E107-444A-A032-0536152E6CFBQ43186538-647A1C09-F6D4-4BCE-8D69-0DCE0D3D54ABQ55002323-5C70026D-11B4-4FD2-8952-3388FD302C78Q55025005-A505AB5A-E14E-4DD6-9294-F33EB64FD06F
P2860
The ethical challenge of infection-inducing challenge experiments
description
im September 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 05 September 2001
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2001
@uk
name
The ethical challenge of infection-inducing challenge experiments
@en
The ethical challenge of infection-inducing challenge experiments
@nl
type
label
The ethical challenge of infection-inducing challenge experiments
@en
The ethical challenge of infection-inducing challenge experiments
@nl
prefLabel
The ethical challenge of infection-inducing challenge experiments
@en
The ethical challenge of infection-inducing challenge experiments
@nl
P356
P1476
The ethical challenge of infection-inducing challenge experiments
@en
P2093
P304
P356
10.1086/322664
P407
P577
2001-09-05T00:00:00Z